Inovio Pharmaceuticals Stock Price

-0.10 (-0.43%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Inovio Pharmaceuticals Inc New INO NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.11 0.47% 23.38 22.65 23.65 23.15 23.27 19:59:11
Bid Price Ask Price Spread Spread % News
23.25 23.28 0.03 0.13% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
71,257 16,854,223 $ 23.18 $ 390,754,711 43,744,173 1.915 - 35.50
Last Trade Time Type Quantity Stock Price Currency
19:59:44 formt 499 $ 23.28 USD

Inovio Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.70B 158.10M 154.69M $ 4.11M $ - -1.23 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Inovio Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical INO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week21.6224.9919.5323.0038,416,4341.768.14%
1 Month12.6135.5012.5224.2057,742,43510.7785.41%
3 Months8.0035.507.5417.7044,671,89315.38192.25%
6 Months3.1835.503.0413.6735,681,35020.20635.22%
1 Year3.0135.501.91513.4418,220,81520.37676.74%
3 Years7.8435.501.91512.486,940,00915.54198.21%
5 Years7.3835.501.91511.964,695,35416.00216.8%

Inovio Pharmaceuticals Description

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.